Patients with end stage renal disease (GFR <15mL/min/1.73m 2): maximum daily dose is 30 mg. Administration of 60 mg Vyvanse chewable tablet with food (a high-fat meal) decreases the exposure (C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results